Txt Now 2 Decrease Pregnancies L8r: A Study to Evaluate the Effect of Daily Text Message Reminders on Pill Continuation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00677703 |
Recruitment Status :
Completed
First Posted : May 14, 2008
Last Update Posted : November 19, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Contraceptives, Oral | Other: Daily Text Messages | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 968 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Official Title: | The Effect of Text Message Reminders on Contraceptive Continuation, a Randomized Controlled Trial |
Study Start Date : | January 2008 |
Actual Primary Completion Date : | April 2010 |
Actual Study Completion Date : | July 2012 |
Arm | Intervention/treatment |
---|---|
No Intervention: Standard Care
Participants will receive standard care without daily reminders.
|
|
Experimental: Text Messages
Participants will receive a daily text message reminder for 6 months
|
Other: Daily Text Messages
Text message reminders to take oral contraception daily: Each text message will be a short educational message listing the benefits of contraceptive use and providing instructions for avoiding common medication errors. Other Name: Text Messaging |
- contraceptive continuation [ Time Frame: 6 months ]
- change in contraceptive knowledge scores [ Time Frame: 6 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 24 Years (Child, Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- aged <25 years requesting OC as their primary method of contraception
- currently sexually active or anticipating sexual activity within the next 30 days
- owns cell phone with text messaging capability
Exclusion Criteria:
- contraindications to combined hormonal contraception per clinic protocol (e.g., hypertension)
- previous participation in this study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00677703
United States, New York | |
Planned Parenthood Boro Hall | |
Brooklyn, New York, United States, 11201 |
Principal Investigator: | Paula M Castano, MD, MPH | Columbia University |
Other Publications:
Responsible Party: | Paula Castano, Assistant Clinical Professor, Columbia University |
ClinicalTrials.gov Identifier: | NCT00677703 |
Other Study ID Numbers: |
AAAC1600 |
First Posted: | May 14, 2008 Key Record Dates |
Last Update Posted: | November 19, 2012 |
Last Verified: | November 2012 |
birth control pills contraception continuation |
text messaging contraceptive continuation contraceptive knowledge |